Health
Evidence of robust and persistent antibodies against SARS-CoV-2 – News-Medical.Net
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions…
A team of researchers from the Icahn School of Medicine at Mount Sinai, New York, have worked in collaboration to try and answer one of the most baffling questions surrounding the coronavirus disease 19 (COVID-19) pandemic: do antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) last after a primary infection? And, if the antibodies remain active, for how long can they be relied upon as protection against the infection? Over 47.3 million people worldwide have been…
-
General24 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News23 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
Noosa News13 hours agoAlternative pathways to university explained
-
Noosa News18 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged
